Anadolu Medical Center
Il Dr. Mustafa Solak è specializzato nei casi di timoma con formazione di fellowship presso l'Istituto Oncologico dell'Università di Hacettepe.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.
Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.
Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.
Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.
Thymoma treatment in Turkey utilizes a multidisciplinary approach combining surgical resection with advanced oncological therapies. Leading centers in Istanbul use international NCCN and ESMO protocols. Most patients undergo thymectomy via robotic surgery or VATS. Advanced cases require neoadjuvant chemotherapy or precision radiation using Truebeam technology.
Bookimed Expert Insight: Data across major Istanbul centers like Medipol and Anadolu reveals a distinct focus on high-volume oncology. Medipol Mega University Hospital serves over 1,000,000 patients annually. This massive logistical capacity ensures specialized equipment like Gamma Knives is always available. Such high patient throughput typically correlates with streamlined, well-coordinated multidisciplinary tumor boards.
Patient Consensus: Patients emphasize finding surgeons highly experienced in mediastinal tumors for successful complete resection. Many note the importance of checking if hospitals bundle oncology consultations with advanced imaging like PET-CT.
Turkish oncology centers feature JCI-accredited infrastructure and surgeons with international fellowships. Facilities like Anadolu Medical Center affiliate with Johns Hopkins for American-standard care. Specialized teams utilize da Vinci XI robotic systems and Video-Assisted Thoracoscopic Surgery to ensure precise tumor removal with faster recovery times.
Bookimed Expert Insight: Clinical volume is a major quality indicator in Turkey. Medipol Mega University Hospital serves over 1,000,000 patients annually and manages 810 beds. This high volume allows surgeons to maintain rare expertise in complex mediastinal tumors. Choosing these large-scale university centers ensures access to specialized pathology departments for accurate staging.
Patient Consensus: Patients emphasize the importance of having biopsy slides reviewed by specialists at major Istanbul oncology centers. Many note that advanced imaging and robotic options are more accessible than in their home countries.
Recovery from minimally invasive thymoma surgery in Turkey involves a 2 to 5 day hospital stay. Patients typically return to light activities within 2 to 4 weeks. Minimally invasive techniques like robotic surgery provide faster healing, less blood loss, and smaller incisions than open surgery.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center and Memorial Şişli maintain high standards through JCI accreditation. Data Shows that clinics with over 65,000 annual patients often offer multi-disciplinary follow-up care. This volume ensures surgeons have extensive experience with robotic systems like da Vinci XI.
Patient Consensus: Many patients find internal fatigue surprising even when external incisions look healed. They emphasize that while hospital discharge is fast, you should plan for assistance with meals and chores at home.
Turkey excels in thymoma treatment through JCI-accredited centers that utilize robotic systems like Da Vinci XI and specialized thoracic surgery teams. Leading hospitals such as Anadolu Medical Center and Istanbul Florence Nightingale integrate multidisciplinary tumor boards. These centers combine advanced imaging with minimally invasive surgical techniques for mediastinal mass excision.
Bookimed Expert Insight: Data shows a clear distinction between standard oncology clinics and major academic hubs like Medipol Mega or Istanbul Florence Nightingale. These institutions serve up to 1,000,000 patients annually and maintain 11 to 25 operating rooms each. This high volume often correlates with greater surgical precision in rare thoracic cases. Choosing a center with specialized equipment like MR Linac ensures that even complex tumors near vital organs are managed with high accuracy.
Patient Consensus: Patients emphasize the importance of bringing original biopsy slides for a second pathology opinion. They specifically value teams where thoracic surgeons and oncologists collaborate on the surgical plan.
Turkish JCI-accredited hospitals provide comprehensive multidisciplinary care for thymoma through dedicated thoracic oncology teams. Leading centers like Anadolu Medical Center and Memorial Şişli Hospital utilize integrated protocols. These include robotic surgery (da Vinci XI), precision radiation therapy (TrueBeam STx), and advanced PET/CT diagnostics for accurate staging.
Bookimed Expert Insight: Case volume directly correlates with precision in thymoma treatment. High-capacity centers like Medipol Mega and Florence Nightingale serve over 300,000 patients annually. These institutions provide critical access to sub-specialized tumor boards. This is vital for thymoma patients who also require neurology input for myasthenia gravis management.
Patient Consensus: Patients emphasize the importance of thorough diagnostics and coordinated care. Many note that accessing experienced teams at large referral centers provides necessary confidence in complex thoracic procedures.